SK282651B6 - Spôsob výroby formylimidazolov - Google Patents

Spôsob výroby formylimidazolov Download PDF

Info

Publication number
SK282651B6
SK282651B6 SK1457-98A SK145798A SK282651B6 SK 282651 B6 SK282651 B6 SK 282651B6 SK 145798 A SK145798 A SK 145798A SK 282651 B6 SK282651 B6 SK 282651B6
Authority
SK
Slovakia
Prior art keywords
process according
catalyst
butyl
formylimidazoles
catalytic oxidation
Prior art date
Application number
SK1457-98A
Other languages
English (en)
Slovak (sk)
Other versions
SK145798A3 (en
Inventor
Josef Heveling
Alain Wellig
Original Assignee
Lonza Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lonza Ag filed Critical Lonza Ag
Publication of SK145798A3 publication Critical patent/SK145798A3/sk
Publication of SK282651B6 publication Critical patent/SK282651B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/68—Halogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
    • B01J23/54—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals combined with metals, oxides or hydroxides provided for in groups B01J23/02 - B01J23/36
    • B01J23/56—Platinum group metals
    • B01J23/62—Platinum group metals with gallium, indium, thallium, germanium, tin or lead
    • B01J23/622—Platinum group metals with gallium, indium, thallium, germanium, tin or lead with germanium, tin or lead
    • B01J23/628—Platinum group metals with gallium, indium, thallium, germanium, tin or lead with germanium, tin or lead with lead
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
    • B01J23/54—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals combined with metals, oxides or hydroxides provided for in groups B01J23/02 - B01J23/36
    • B01J23/56—Platinum group metals
    • B01J23/64—Platinum group metals with arsenic, antimony, bismuth, vanadium, niobium, tantalum, polonium, chromium, molybdenum, tungsten, manganese, technetium or rhenium
    • B01J23/644—Arsenic, antimony or bismuth
    • B01J23/6447—Bismuth
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Steroid Compounds (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SK1457-98A 1997-10-29 1998-10-21 Spôsob výroby formylimidazolov SK282651B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH250497 1997-10-29

Publications (2)

Publication Number Publication Date
SK145798A3 SK145798A3 (en) 1999-05-07
SK282651B6 true SK282651B6 (sk) 2002-11-06

Family

ID=4235293

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1457-98A SK282651B6 (sk) 1997-10-29 1998-10-21 Spôsob výroby formylimidazolov

Country Status (17)

Country Link
US (1) US5917051A (ko)
EP (1) EP0913394B1 (ko)
JP (1) JP4423684B2 (ko)
KR (1) KR100587187B1 (ko)
CN (1) CN1120158C (ko)
AT (1) ATE313533T1 (ko)
CA (1) CA2251401C (ko)
CZ (1) CZ291600B6 (ko)
DE (1) DE59813294D1 (ko)
DK (1) DK0913394T3 (ko)
ES (1) ES2255726T3 (ko)
HU (1) HU221057B1 (ko)
NO (1) NO309980B1 (ko)
PL (1) PL197849B1 (ko)
PT (1) PT913394E (ko)
SK (1) SK282651B6 (ko)
TW (1) TW466235B (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100567183B1 (ko) * 1997-11-14 2006-06-13 론자 아게 포르밀이미다졸의제조방법
ES2296348T3 (es) * 1997-11-14 2008-04-16 Lonza Ag Procedimiento de produccion de formilimidazoles.
US20010014743A1 (en) 1997-11-14 2001-08-16 Lonza Ag Procedure for producing formylimidazoles
CA2334901C (en) * 1998-06-15 2009-03-17 Lonza Ag Procedure for producing formyl imidazoles
JP2000053651A (ja) * 1998-06-18 2000-02-22 Lonza Ag ホルミルイミダゾ―ル類の製造方法
EP0965590A1 (de) * 1998-06-18 1999-12-22 Lonza A.G. Verfahren zur Herstellung von Formylimidazolen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9110532D0 (en) * 1991-05-15 1991-07-03 Smithkline Beecham Corp Chemical compounds
US5336779A (en) * 1992-10-08 1994-08-09 Nippon Gohsei Kagaku Kogyo Kabushiki Kaisha Method of producing formylimidazoles

Also Published As

Publication number Publication date
HUP9802495A3 (en) 2000-04-28
SK145798A3 (en) 1999-05-07
JPH11209348A (ja) 1999-08-03
HU221057B1 (hu) 2002-07-29
US5917051A (en) 1999-06-29
KR100587187B1 (ko) 2006-10-24
JP4423684B2 (ja) 2010-03-03
HU9802495D0 (en) 1999-01-28
EP0913394A1 (de) 1999-05-06
PL329422A1 (en) 1999-05-10
CA2251401C (en) 2007-09-25
CZ291600B6 (cs) 2003-04-16
CZ339598A3 (cs) 1999-05-12
ATE313533T1 (de) 2006-01-15
HUP9802495A2 (hu) 1999-07-28
EP0913394B1 (de) 2005-12-21
DK0913394T3 (da) 2006-05-08
NO985013D0 (no) 1998-10-28
CA2251401A1 (en) 1999-04-29
PT913394E (pt) 2006-05-31
CN1120158C (zh) 2003-09-03
ES2255726T3 (es) 2006-07-01
DE59813294D1 (de) 2006-01-26
PL197849B1 (pl) 2008-05-30
KR19990037077A (ko) 1999-05-25
CN1220990A (zh) 1999-06-30
TW466235B (en) 2001-12-01
NO985013L (no) 1999-04-30
NO309980B1 (no) 2001-04-30

Similar Documents

Publication Publication Date Title
SK282651B6 (sk) Spôsob výroby formylimidazolov
US6040457A (en) Process for the preparation of formylimidazoles
DK165832B (da) Fremgangsmaade til fremstilling af 2-carboxy-pyrazin-4-oxider
CA2309856C (en) Process for the production of formylimidazoles
US6258958B1 (en) Procedure for producing formyl imidazoles
US6469178B2 (en) Procedure for producing formylimidazoles
MXPA00004736A (en) Process for the production of formylimidazoles
CZ20001764A3 (cs) Způsob přípravy formylimidazolů

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20131021